TOLERO PHARMACEUTICALS

tolero-pharmaceuticals-logo

Tolero Pharmaceuticals is a biopharmaceutical company that discovers and develops novel therapeutics to treat and cure cancer and other life-threatening diseases in the United States. Its products include TP-0413 that targets a signaling pathway complicated in the regulation of serum iron levels for individuals suffering from chronic inflammatory diseases, such as cancer and rheumatoid arthritis; TP-0829, which targets a vital component of the B-cell receptor signaling pathway for the treatment ... of B-cell lymphomas, B-cell leukemia, and multiple myeloma; and TP-0903, a dual-targeted agent that inhibits two signaling pathways for pancreatic cancer cell growth and survival, and for the maintenance of the tumor stromal cells. The company’s products also comprise TP-0227 that targets a signaling pathway deregulated in cancer cells particularly in endometrial carcinomas; and TP-1149 which targets a cellular mechanism to render myeloma cells resistant to current therapeutic approaches. Tolero Pharmaceuticals, Inc. has a strategic partnership with MannKind Corporation. The company was founded in 2011 and is based in Salt Lake City, Utah.

#SimilarOrganizations #People #Financial #Website #More

TOLERO PHARMACEUTICALS

Social Links:

Industry:
Biotechnology Health Care Pharmaceutical

Founded:
2011-01-01

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.toleropharmaceuticals.com

Total Employee:
11+

Status:
Active

Contact:
801-285-6003

Total Funding:
25.93 M USD

Technology used in webpage:
SPF Amazon AJAX Libraries API GoDaddy DNS AWS Global Accelerator


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

celator-pharmaceuticals-logo

Celator Pharmaceuticals

Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.

forma-therapeutics-logo

FORMA Therapeutics

FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.

nanomed-pharameceuticals-logo

Nanomed Pharameceuticals

NanoMed Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutic products to treat cancer and other diseases.

reata-pharmaceuticals-logo

Reata Pharmaceuticals

Reata Pharmaceuticals is a biopharmaceutical company that develops drugs for cancer, inflammation, and neurodegenerative diseases.

recro-pharma-logo

Recro Pharma

Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

Current Employees Featured

david-j-bearss_image

David J. Bearss
David J. Bearss Founder and Chief Executive Officer @ Tolero Pharmaceuticals
Founder and Chief Executive Officer

daniel-hoff_image

Daniel Hoff
Daniel Hoff Senior Vice President of Clinical Development @ Tolero Pharmaceuticals
Senior Vice President of Clinical Development

dallin-m-anderson_image

Dallin M. Anderson
Dallin M. Anderson Founder @ Tolero Pharmaceuticals
Founder

Founder


dallin-m-anderson_image

Dallin M. Anderson

david-j-bearss_image

David J. Bearss

Investors List

alger_image

Alger

Alger investment in Series B - Tolero Pharmaceuticals

alger_image

Alger

Alger investment in Series B - Tolero Pharmaceuticals

Official Site Inspections

http://www.toleropharmaceuticals.com

  • Host name: a4ec4c6ea1c92e2e6.awsglobalaccelerator.com
  • IP address: 3.33.152.147
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "Tolero Pharmaceuticals"

Tolero Pharmaceuticals - Crunchbase Company Profile & Funding

Tolero Pharmaceuticals is a biopharmaceutical company that develops novel therapeutics to treat cancer and other life-threatening diseases.See details»

Tolero Pharmaceuticals, Inc. - LinkedIn

Tolero Pharmaceuticals is a clinical stage biopharmaceutical company developing treatments to improve and extend the lives of patients with serious oncological and hematological diseases. …See details»

Tolero Pharmaceuticals, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Tolero Pharmaceuticals, Inc. of Lehi, UT. Get the latest business insights from Dun & Bradstreet.See details»

Tolero Pharmaceuticals: Revenue, Worth, Valuation & Competitors …

Tolero Pharmaceuticals is a Pharmaceuticals related company founded in 2011 and based in Salt Lake City with an estimated revenue of $804K, and 4 employees. It has 10 competitors …See details»

Tolero Pharmaceuticals Inc - Company Profile and News

Company profile page for Tolero Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»

Tolero Pharmaceuticals - PitchBook

Information on acquisition, funding, investors, and executives for Tolero Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»

Tolero Pharmaceuticals, Inc. - Company Profile - Corporation Wiki

View company leaders and background information for Tolero Pharmaceuticals, Inc. Search our database of over 100 million company and executive profiles.See details»

Sumitomo Dainippon Pharma Completes Acquisition of Tolero ...

Jan 26, 2017 A description of this acquisition was disclosed in the announcement "Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company)" …See details»

Tolero Pharmaceuticals, Inc. (Tolero Pharmaceuticals, Inc.) - 药物管 …

Before taking on his role as chief scientific officer at Halia in January 2021 and assuming the CEO position in March 2022, Dr. Bearss served as the CEO of Tolero Pharmaceuticals, an …See details»

Organization | Tolero Pharmaceuticals

Mergers & Acquisitions Historical Acquisition Tree Alternative names Tolero Pharmaceuticals | Tolero Pharmaceuticals, Inc. Active Ingredients Drugs in Phase 2 Trials (6) alvocidib ( 5 trials ) …See details»

Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, …

Print(PDF/152KB) Dec. 21, 2016 Corporate Sumitomo Dainippon Pharma to Acquire Tolero Pharmaceuticals, Inc. (US Biotechnology Company) Sumitomo Dainippon Pharma Co., Ltd. …See details»

Tolero Pharmaceuticals - Products, Competitors, Financials, …

About Tolero Pharmaceuticals Tolero Pharmaceuticals is a biotechnology company specializing in the research and development of therapeutic agents in the areas of oncology and …See details»

Tolero Pharmaceuticals Lehi UT, 84043 – Manta.com

Get information, directions, products, services, phone numbers, and reviews on Tolero Pharmaceuticals in Lehi, undefined Discover more Pharmaceutical Preparations companies in …See details»

Tolero Pharmaceuticals, Inc.’s Competitors, Revenue, Number of ...

Tolero Pharmaceuticals, Inc.’s Profile, Revenue and Employees. Tolero Pharmaceuticals discovers and develops novel therapeutics for the treatment of oncology and hematologic …See details»

Tolero Pharmaceuticals signs clinical research collaboration with ...

Aug 20, 2018 US-based Tolero Pharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases, has …See details»

What is Tolero Pharmaceuticals? Company Culture, Mission, Values

See what employees say it's like to work at Tolero Pharmaceuticals. Salaries, reviews, and more - all posted by employees working at Tolero Pharmaceuticals.See details»

Japanese pharma snaps up cancer biotech Tolero | BioPharma Dive

Dec 22, 2016 Dive Brief: Japanese pharmaco Sumitomo Dainippon Pharma has picked up oncology and hematology biotech Tolero Pharmaceuticals for up to $780 million. This …See details»

Tolero Pharmaceuticals, Inc.: Read reviews and ask questions

About Tolero Pharmaceuticals, Inc. Tolero is a clinical-stage biopharmaceutical company with a single-minded purpose: to alleviate human suffering through the development of meaningful …See details»

Michael V. Mccullar | Tolero Pharmaceuticals | United States of …

Dr. Michael V. McCullar serves as the Chief Operating Officer for Tolero Pharmaceuticals. Most recently, Dr. McCullar served as Senior Vice President of Busine..See details»

Tolero Pharmaceuticals Announces Clinical Research Collaboration …

Tolero Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases, has entered into a clinical research …See details»

linkstock.net © 2022. All rights reserved